For the year ending 2025-12-31, ANIK has $190,270K in assets. $57,481K in cash and cash equivalents.
| Balance Sheets | 2025-12-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 57,481 | |||
| Accounts receivable, net | 23,690 | |||
| Inventories | 18,787 | |||
| Prepaid expenses and other current assets | 3,400 | |||
| Current assets held for sale | 0 | |||
| Total current assets | 103,358 | |||
| Property, plant and equipment, gross | 91,752 | |||
| Less accumulated depreciation | 51,428 | |||
| Property and equipment, net | 40,324 | |||
| Right-of-use assets | 25,939 | |||
| Other long-term assets | 4,034 | |||
| Notes receivable | 5,636 | |||
| Deferred tax assets | 1,275 | |||
| Intangible assets, net | 1,650 | |||
| Goodwill | 8,054 | |||
| Non-current assets held for sale | 0 | |||
| Total assets | 190,270 | |||
| Accounts payable | 6,041 | |||
| Accrued expenses and other current liabilities | 15,867 | |||
| Current liabilities held for sale | 0 | |||
| Total current liabilities | 21,908 | |||
| Other long-term liabilities | 701 | |||
| Lease liabilities | 24,196 | |||
| Non-current liabilities held for sale | 0 | |||
| Common stock, .01 par value 90,000 shares authorized, 15,385 issued and 13,889 outstanding and 15,010 shares issued and 14,416 outstanding at december 31, 2025 and 2024, respectively | 139 | |||
| Additional paid-in-capital | 87,498 | |||
| Accumulated other comprehensive loss | -4,959 | |||
| Retained earnings | 60,787 | |||
| Total stockholders equity | 143,465 | |||
| Total liabilities and stockholders equity | 190,270 | |||
Anika Therapeutics, Inc. (ANIK)
Anika Therapeutics, Inc. (ANIK)